Brava Diagnostics
Boulder, US · Founded 2018 · Delaware corporation
Biotech
Founders & leadership
CM
Chris MyattNamed on SEC filing
RS
Robert SilvermanNamed on SEC filing
BH
Byron HewettNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 2 rounds · 2018–2019
▶$250KraisedSep 2019 · 3 investors · BiotechnologyRule 506(b)
▶$250KraisedSep 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chris MyattDirector
- Robert SilvermanDirector, Promoter
- Carrie MulherinPromoter
- David OkronglyPromoter
- Byron HewettExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $250K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$4MraisedNov 2018 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedNov 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chris MyattDirector
- Robert SilvermanDirector, Promoter
- David OkronglyPromoter
- Carrie MulherinPromoter
- Byron HewettExecutive Officer, Director, Promoter
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Brava Diagnostics raised?
- Brava Diagnostics has disclosed $4.3M raised across 2 rounds.
- Where is Brava Diagnostics headquartered?
- Brava Diagnostics is headquartered in Boulder, US.